CrisprBits
PrivateLast Round
Series A
Nov 25, 2025
Est. Valuation
$12M
Total Funding Raised
$3.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CrisprBits operates in Healthcare & Life Sciences and is based in Delhi. Its latest recorded funding round was a Series A round in November 2025.
CrisprBits is a biotechnology company that develops diagnostic tests and gene-editing technology platforms for healthcare, food safety, and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Revenue Share, Hardware Sales
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CrisprBits Comparables
Compare CrisprBits with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VedaBio | 79% | |
| IntelliGenome | 78% | |
| OraSure Technologies Inc | 77% |
For institutional investors. Book with your work email.
CrisprBits Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 25, 2025 | ||||
| Pre Seed | Feb 13, 2023 |
For institutional investors. Book with your work email.
CrisprBits Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Spectrum Impact | Series A |
| Centre for Cellular and Molecular Platforms | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
$3M round led by Spectrum Impact.
- Aug 25, 2025
Grew 27% QoQ, from 22 to 28 employees.
For institutional investors. Book with your work email.
CrisprBits Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CrisprBits's valuation, stock price, and market status.
Is CrisprBits a public or private company?
CrisprBits is a private company.
What is the current stock price of CrisprBits?
CrisprBits is a private company, so its shares have no public market price. Caplight tracks CrisprBits's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CrisprBits worth (valuation)?
CrisprBits's valuation is estimated at $12.0M based on funding round data.
Can I buy CrisprBits stock?
CrisprBits shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CrisprBits's last funding round?
CrisprBits's most recent funding round was Series A on November 25, 2025.
Who are the main investors in CrisprBits?
Key investors in CrisprBits include Spectrum Impact.
Will CrisprBits IPO soon?
No public IPO plans have been announced for CrisprBits.
How can I track CrisprBits secondary market activity?
Caplight tracks bids, offers, and trades in CrisprBits's shares on secondary markets.